Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria

Gelijkaardige items

• OS10.1 Survival analysis of IDH wildtype astrocytomas with molecular features of glioblastoma, WHO grade IV
  door: Tesileanu, C M S, et al.
  Gepubliceerd in: (2019)
• Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation
  door: Incekara, Fatih, et al.
  Gepubliceerd in: (2020)
• The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
  door: Incekara, Fatih, et al.
  Gepubliceerd in: (2020)
• SURG-30. CLINICAL COURSE OF IDH-MUTATED LOW-GRADE GLIOMAS DURING THE POSTSURGICAL ACTIVE MONITORING PHASE: ASYMPTOMATIC PATIENTS, WELL CONTROLLED SEIZURES, BUT CONTINUOUS GROWTH OF TUMOR RESIDUES
  door: Wijnenga, Maarten, et al.
  Gepubliceerd in: (2019)
• Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
  door: Wijnenga, Maarten M. J., et al.
  Gepubliceerd in: (2018)